carcinoembryonic antigen , CEA (Abkürzung)

Another example is carcinoembryonic antigen, which is elevated in people with colon cancer and other tumors.

In humans, the carcinoembryonic antigen family consists of 29 genes, 18 of which are normally expressed.

Carcinoembryonic antigen (CEA) is a marker found in several forms of cancer.

The only blood test now available for monitoring patients with colorectal cancer is called the carcinoembryonic antigen assay, which detects another protein.

Carcinoembryonic antigen (CEA) blood test to check whether colorectal cancer has returned.

A carcinoembryonic antigen (CEA) blood test to check the level of this tumor marker.

Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion.

The patent covers a class of antibodies that attack a molecule known as carcinoembryonic antigen, or CEA.

The blood levels of carcinoembryonic antigen (CEA; a substance in the blood that may be increased when cancer is present) before treatment begins.

In some cases, the pericardial fluid may be checked for other substances (such as carcinoembryonic antigen, or CEA).

Carcinoembryonic antigen blood level measurements follow the same timing, but are only advised for patients with T2 or greater lesions who are candidates for intervention.

Carcinoembryonic antigen (CEA): used for identification of adenocarcinomas.

CEACAM19 is a gene which encodes carcinoembryonic antigen.

Examples where the sensitivity and specificity change between different sub-groups of patients may be found with the carcinoembryonic antigen test and urinary dipstick tests.

Carcinoembryonic antigen (CEA).

The first winner of the Principal Award in 1982 was Phil Gold for his discovery of carcinoembryonic antigen, now widely used for cancer blood testing.

Arcitumomab recognizes carcinoembryonic antigen (CEA), an antigen over-expressed in 95% of colorectal cancers.

These results are similar to those of Heyderman et al, who found that 20 out of 22 primary pancreatic tumours focally or weakly stained for carcinoembryonic antigen.

Blood tests to detect tumor markers, including carcinoembryonic antigen (CEA) and CA 19-9, may help your physician follow you during and after treatment.

Goldstein MJ, Mitchell EP: Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer.

Carcinoembryonic antigen (CEA) assay: A test that measures the level of CEA in the blood.

The vaccine targets two proteins, mucin-1 (MUC-1) and carcinoembryonic antigen (CEA), Gulley says.

Serum levels of carcinoembryonic antigen (CEA) and CA19-9 are often elevated, but are not sensitive or specific enough to be used as a general screening tool.

In 1965, he co-discovered with Phil Gold the carcinoembryonic antigen, the basis of a blood test used in the diagnosis and management of people with colorectal cancer.

Such tumor markers are, for instance, CEA (carcinoembryonic antigen) and AFP (alpha fetoprotein).